These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36192413)

  • 1. Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy.
    Toh YL; Tan CJ; Yap NY; Parajuli R; Lau AJ; Chan A
    Sci Rep; 2022 Oct; 12(1):16552. PubMed ID: 36192413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
    Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
    Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
    Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
    Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
    Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
    Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
    Guazzo EP; Kirkpatrick PJ; Goodyer IM; Shiers HM; Herbert J
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenopause or decline of serum adrenal androgens with age in women living at sea level or at high altitude.
    Gonzales GF; Góñez C; Villena A
    J Endocrinol; 2002 Apr; 173(1):95-101. PubMed ID: 11927388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.
    Wagner LI; Gray RJ; Sparano JA; Whelan TJ; Garcia SF; Yanez B; Tevaarwerk AJ; Carlos RC; Albain KS; Olson JA; Goetz MP; Pritchard KI; Hayes DF; Geyer CE; Dees EC; McCaskill-Stevens WJ; Minasian LM; Sledge GW; Cella D
    J Clin Oncol; 2020 Jun; 38(17):1875-1886. PubMed ID: 32271671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment.
    Yap NY; Toh YL; Tan CJ; Acharya MM; Chan A
    Cytokine; 2021 Aug; 144():155556. PubMed ID: 33985854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.
    Legrain S; Girard L
    Drugs Aging; 2003; 20(13):949-67. PubMed ID: 14561100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone and age-related cognitive decline.
    Sorwell KG; Urbanski HF
    Age (Dordr); 2010 Mar; 32(1):61-7. PubMed ID: 19711196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study.
    Duivon M; Lequesne J; Di Meglio A; Pradon C; Vaz-Luis I; Martin AL; Everhard S; Broutin S; Rigal O; Bousrih C; Lévy C; Lerebours F; Lange M; Joly F
    Breast Cancer Res; 2024 Jun; 26(1):93. PubMed ID: 38840166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus.
    Zhang X; Xiao J; Liu T; He Q; Cui J; Tang S; Li X; Liu M
    Front Endocrinol (Lausanne); 2022; 13():890029. PubMed ID: 35832423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
    Arlt W; Haas J; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHEAS prevents pro-metastatic and proliferative effects of 17ß-estradiol on MCF-7 breast cancer cells.
    Upmanyu N; Bulldan A; Failing K; Scheiner-Bobis G
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118600. PubMed ID: 31760088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line.
    Poulin R; Labrie F
    Cancer Res; 1986 Oct; 46(10):4933-7. PubMed ID: 2944574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen replacement therapy on dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol responses to exercise in postmenopausal women.
    Johnson LG; Kraemer RR; Haltom R; Kraemer GR; Gaines HE; Castracane VD
    Fertil Steril; 1997 Nov; 68(5):836-43. PubMed ID: 9389812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study.
    Johannes CB; Stellato RK; Feldman HA; Longcope C; McKinlay JB
    J Clin Epidemiol; 1999 Feb; 52(2):95-103. PubMed ID: 10201649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.